Latest 8-K filings

Ensysce Biosciences, Inc. announced the resignation of its Chief Operating Officer, Jeffrey Millard, effective July 10, 2026.

Ribbon Acquisition Corp. has deposited $125,000 to extend its business combination deadline by one month to August 15, 2026.

Celsius Holdings, Inc. has entered into a second refinancing amendment to its credit agreement, reducing interest rates on its term loan facility and repaying an existing term loan with proceeds from a new, lower-interest loan.

Lakewood-Amedex Biotherapeutics Inc. has released an investor presentation detailing its Bisphosphocin compounds, focusing on the lead program Nu-3 for infected diabetic foot ulcers.

InPoint Commercial Real Estate Income, Inc. reported its Net Asset Value per share as of June 30, 2026, with an aggregate NAV of $133,906,000.

Cytek Biosciences announces departure of Chief Legal Officer and Corporate Secretary, Valerie Barnett, with a severance package and consulting agreement.

John B. Sanfilippo & Son, Inc. announced a special cash dividend of $1.05 per share and an annual cash dividend of $0.95 per share, returning approximately $23.6 million to stockholders.

Aspira Women's Health Inc. has entered into a Subordinated Business Loan and Security Agreement for a $1.05 million term loan to refinance existing debt and fund general corporate purposes.

Jefferies Financial Group Inc. has successfully completed a public offering of $850 million in 4.500% Senior Notes due 2033, with net proceeds estimated at $843.8 million for general corporate purposes.

Liberty Capital Corporation announced it will host a conference call on August 6th, 2026, to discuss its second quarter 2026 financial results and outlook.

Mobia Medical, Inc. has expanded its Board of Directors to seven members with the appointment of Dr. Reza Zadno, who will also serve on the Compensation Committee.

Azitra, Inc. reported promising ex vivo human skin tissue study results for its ATR-COSF program, demonstrating increased distribution and anti-wrinkle effects.

Frequency Electronics announced its fiscal year 2026 financial results, highlighting a significant increase in funded backlog to $111 million and setting new minimum gross and operating margin targets for fiscal year 2029.

RLI Corp. announced the appointment of James H. Bradshaw to its Board of Directors, effective July 15, 2026, bringing extensive insurance industry experience.

Marwynn Holdings, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, avoiding potential delisting.

Martin Marietta Materials, Inc. has amended its revolving credit facility and entered into a new term credit agreement, totaling $2.3 billion, to support its acquisition of Lhoist North America, Inc.

Celldex Therapeutics announces the planned retirement of CFO Sam Martin, effective March 31, 2027, with a search for his successor underway.

LCNB Corp. announced record second quarter 2026 financial results, driven by a significant increase in net interest income and strong growth in wealth management.

Vaxcyte, Inc. reports the retirement of Heath Lukatch from its Board of Directors and the appointment of John Markels as a new Class II director.

Edgemode, Inc. has entered into a leakout agreement with lenders holding convertible promissory notes totaling approximately $1.65 million, restricting conversion and transfer percentages until December 31, 2026.

Carlyle Credit Income Fund reports unaudited net asset value per common share of $3.32 as of June 30, 2026.

Alamar Biosciences announced the passing of board member Ian Ratcliffe and subsequent adjustments to its board size and committee appointments.

Prestige Consumer Healthcare Inc. announced the issuance of $400 million in 6.250% senior notes due 2034 through its subsidiary, Prestige Brands, Inc.

Aeon Biopharma announced the pricing of its underwritten public offering, raising up to $13.75 million with potential for additional future funding through milestone warrants.

Carlyle Secured Lending, Inc. announced it will release its second quarter 2026 financial results on August 6, 2026, followed by a conference call on August 7, 2026.

BayFirst Financial Corp. announced the quantification of its asset resolution plan and the restatement of prior financial statements due to identified accounting errors.

MetroCity Bankshares, Inc. announced the declaration of a quarterly cash dividend of $0.29 per share, payable on August 7, 2026.

Republic Bancorp, Inc. announced its third quarter 2026 cash dividend for Class A and Class B common stock.

United Airlines reported strong second-quarter 2026 results, exceeding Wall Street expectations and raising full-year adjusted EPS guidance despite significant increases in fuel costs.

High Wire Networks announced that previously issued financial statements for three quarters in 2025 must be restated due to accounting errors related to loan defaults.